tazarotene gel 0.1%

DRUG3 trials

Sponsors

Allergan, Post Graduate Institute of Medical Education and Research, Chandigarh, Jinnah Postgraduate Medical Centre

Conditions

Acne ScarAcne VulgarisAtrophic Post Acne Scarring

Phase 1

Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris

CompletedNCT02218034

AllerganAcne Vulgaris

Start: 2014-08-31End: 2015-03-31Updated: 2015-04-30

Phase 2

Comparing the Efficacy of Topical Tazarotene Gel 0.1% v/s Microneedling in Atrophic Post Acne Scars

CompletedNCT05573425

Jinnah Postgraduate Medical CentreAcne Scar

Start: 2020-08-22End: 2021-02-21Updated: 2022-10-13

Unknown Phase

Comparison Between Microneedling Daycare Procedure and Tazarotene 0.1% Gel Local Application in Acne Scarring

CompletedNCT03170596

Post Graduate Institute of Medical Education and Research, ChandigarhAtrophic Post Acne Scarring

Start: 2017-06-02End: 2018-03-29Updated: 2018-04-04

Related Papers

Topical Tazarotene Gel, 0.1%, as a Novel Treatment Approach for Atrophic Postacne Scars

JAMA Facial Plastic Surgery2018-11-1935 citations